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Intravenous Iron Improves Exercise Tolerance
Patients with chronic heart failure (CHF) have impaired skeletal muscle oxidativecapacity which causes an early shift to anerobicmetabolism and early fatigue. Iron
is critical for oxidative metabolism. The FERRIC-HF (Ferric Iron Sucrose in Heart
Failure) trial randomized 35 patients with CHF and low ferritin levels, and/or low
transferrin saturations, to intravenous iron sucrose or no treatment. Iron therapy
delayed the onset of anaerobicmetabolism.Benefitsweremoremarked in patientswho
were also anemic, but were present in those without anemia. This study suggests that
normalizing iron stores may improve exercise capacity by increasing the threshold for
skeletal muscle anerobic metabolism in patients with CHF. See page 103.
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Infarction and
Psychosocial Factors
Anxiety Associated With Increased Risk of Myocardial Infarction
Several psychosocial factors have been associated with increased cardiovascular risk,but anxiety has not been examined extensively. Shen and colleagues followed over
700 patients enrolled in the Normative Aging Study who were assessed with the
Minnesota Multiphasic Personality Inventory. Over the next 12 years, those with
anxiety characteristics were more likely to suffer a myocardial infarction, even after
controlling for traditional risk factors and other psychological variables. Subjects in the
highest quartile of anxiety were at almost 3 times higher risk. This study suggests that
patients with anxiety-prone dispositions are at significantly increased risk for future
cardiovascular events. See page 113. See figure.
Heart Failure
and Resynchronization
Response to Cardiac Resynchronization Therapy
Associated With Improvements in Myocardial Gene Expression
Cardiomyocytes from failing ventricles often revert to the “fetal” gene program,with alterations in genes that regulate contractile function and pathologic hyper-
trophy. Vanderheyden and colleagues hypothesized that patients who respond to
cardiac resynchronization therapy (CRT), may normalize their gene expression pro-
files. Left ventricular endomyocardial biopsies were obtained pre- and post-CRT
implantation. Responders to CRT showed an increase in messenger ribonucleic acid
levels of-mysoin heavy chain, sarcoplasmic reticulum calciumATPase 2 (SERCA),
and an increase in the ratio of SERCA/phospholamban. No changes were observed in
nonresponders. Functional improvement related to CRT is associated with favorable
changes in established molecular markers of heart failure. See page 129.
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Cardiac Imaging
Myocardial Fatty Acid Imaging Predicts Cardiac Risk in Dialysis Patients
Over 70% of the energy expended by the normal myocardium under aerobicconditions is derived from free fatty acid metabolism, but during ischemia,
myocytes shift to glucose as an energy source. Single-photon emission computed
tomography (SPECT) using 123iodine–-methyl iodophenyl-pentadecanoic acid
(BMIPP) as a tracer allows the quantification of cardiac fatty acid metabolism. Nish-
imura and colleagues performedSPECT imagingwithBMIPP indialysis patients.The
cardiac death-free survival rates at 3 years were 61% and 98% in patients with BMIPP
summed scores of 12 and 12. This study demonstrates that BMIPP SPECT
imaging can identify patients at high risk for cardiac death, probably by identifying
areas of chronic myocardial ischemia. See page 139. See figure.
